Vincelette J

Title : Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension - Zhang_2011_Eur.J.Pharmacol_654_68

Author(s) : Zhang LN , Vincelette J , Chen D , Gless RD , Anandan SK , Rubanyi GM , Webb HK , MacIntyre DE , Wang YX

Ref : European Journal of Pharmacology , 654 :68 , 2011

Abstract :

PubMedSearch : Zhang_2011_Eur.J.Pharmacol_654_68

PubMedID: 21187082

Title : 1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia - Anandan_2011_Bioorg.Med.Chem.Lett_21_983

Author(s) : Anandan SK , Webb HK , Chen D , Wang YX , Aavula BR , Cases S , Cheng Y , Do ZN , Mehra U , Tran V , Vincelette J , Waszczuk J , White K , Wong KR , Zhang LN , Jones PD , Hammock BD , Patel DV , Whitcomb R , MacIntyre DE , Sabry J , Gless R

Ref : Bioorganic & Medicinal Chemistry Lett , 21 :983 , 2011

Abstract :

PubMedSearch : Anandan_2011_Bioorg.Med.Chem.Lett_21_983

PubMedID: 21211973

Vincelette J

References (2)

1. Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension - Zhang_2011_Eur.J.Pharmacol_654_68

2. 1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia - Anandan_2011_Bioorg.Med.Chem.Lett_21_983